Identifying CSCs involves the use of specific markers and techniques. Common markers include CD133, CD44, and ALDH1. Techniques such as flow cytometry, immunohistochemistry, and sphere formation assays are used to isolate and study these cells. The presence of CSCs is often correlated with poor prognosis and resistance to treatment.
